Cargando…
Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
BACKGROUND/HYPOTHESIS: Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) tr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933116/ https://www.ncbi.nlm.nih.gov/pubmed/36448416 http://dx.doi.org/10.1002/clc.23948 |
_version_ | 1784889605336596480 |
---|---|
author | Brockmeyer, Maximilian Wies, Emilia Joerges, Jamuna Sommer, Jana Borgmann, Sandra Olivia Chernyak, Nadja Lin, Yingfeng Parco, Claudio Schulze, Volker Heinen, Yvonne Kelm, Malte Icks, Andrea Perings, Stefan Wolff, Georg |
author_facet | Brockmeyer, Maximilian Wies, Emilia Joerges, Jamuna Sommer, Jana Borgmann, Sandra Olivia Chernyak, Nadja Lin, Yingfeng Parco, Claudio Schulze, Volker Heinen, Yvonne Kelm, Malte Icks, Andrea Perings, Stefan Wolff, Georg |
author_sort | Brockmeyer, Maximilian |
collection | PubMed |
description | BACKGROUND/HYPOTHESIS: Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) treatment goals, subjective level of information, and information needs in very high‐risk patients with ASCVD. METHODS: ASCVD patients (n = 210; 75 ± 9 years; 71.4% male; 89.5% coronary disease) with DM (96.7% type 2) completed a questionnaire assessing knowledge of HbA1c and LDL‐C treatment goals and subjective level of information and information needs on disease‐related topics of DM and ASCVD. Serum LDL‐C and HbA1c were measured. RESULTS: HbA1c goal (<7.0% in 60.6%) was attained more frequently than LDL‐C goal (<70 mg/dl in 39.9%; p < .01). Significantly more participants named the correct goal for HbA1c compared to LDL‐C (52.9% vs. 2.4%; p < .01). Subjective levels of information were higher and information needs were lower for DM than for ASCVD (p < .01 for all topics). No associations of knowledge of treatment goals and level of information with the attainment of treatment goals for HbA1c and LDL‐C were found. However, in multivariate regression, higher levels of education were associated with knowledge of treatment goals (HbA1c: odds ratio [OR] 1.32, 95% confidence interval [CI] 1.01–1.72, p = .04; LDL‐C: OR 2.32, 95% CI 1.07–5.03; p = .03). CONCLUSION: In very high‐risk patients with ASCVD, a deficit of knowledge of treatment goals to control dyslipidemia exists when compared to DM, patients felt significantly better informed for topics of DM than for ASCVD and display higher information needs for topics of ASCVD. |
format | Online Article Text |
id | pubmed-9933116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99331162023-02-17 Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease Brockmeyer, Maximilian Wies, Emilia Joerges, Jamuna Sommer, Jana Borgmann, Sandra Olivia Chernyak, Nadja Lin, Yingfeng Parco, Claudio Schulze, Volker Heinen, Yvonne Kelm, Malte Icks, Andrea Perings, Stefan Wolff, Georg Clin Cardiol Clinical Trial Result BACKGROUND/HYPOTHESIS: Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) treatment goals, subjective level of information, and information needs in very high‐risk patients with ASCVD. METHODS: ASCVD patients (n = 210; 75 ± 9 years; 71.4% male; 89.5% coronary disease) with DM (96.7% type 2) completed a questionnaire assessing knowledge of HbA1c and LDL‐C treatment goals and subjective level of information and information needs on disease‐related topics of DM and ASCVD. Serum LDL‐C and HbA1c were measured. RESULTS: HbA1c goal (<7.0% in 60.6%) was attained more frequently than LDL‐C goal (<70 mg/dl in 39.9%; p < .01). Significantly more participants named the correct goal for HbA1c compared to LDL‐C (52.9% vs. 2.4%; p < .01). Subjective levels of information were higher and information needs were lower for DM than for ASCVD (p < .01 for all topics). No associations of knowledge of treatment goals and level of information with the attainment of treatment goals for HbA1c and LDL‐C were found. However, in multivariate regression, higher levels of education were associated with knowledge of treatment goals (HbA1c: odds ratio [OR] 1.32, 95% confidence interval [CI] 1.01–1.72, p = .04; LDL‐C: OR 2.32, 95% CI 1.07–5.03; p = .03). CONCLUSION: In very high‐risk patients with ASCVD, a deficit of knowledge of treatment goals to control dyslipidemia exists when compared to DM, patients felt significantly better informed for topics of DM than for ASCVD and display higher information needs for topics of ASCVD. John Wiley and Sons Inc. 2022-11-30 /pmc/articles/PMC9933116/ /pubmed/36448416 http://dx.doi.org/10.1002/clc.23948 Text en © 2022 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Trial Result Brockmeyer, Maximilian Wies, Emilia Joerges, Jamuna Sommer, Jana Borgmann, Sandra Olivia Chernyak, Nadja Lin, Yingfeng Parco, Claudio Schulze, Volker Heinen, Yvonne Kelm, Malte Icks, Andrea Perings, Stefan Wolff, Georg Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease |
title | Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease |
title_full | Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease |
title_fullStr | Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease |
title_full_unstemmed | Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease |
title_short | Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease |
title_sort | knowledge of hba1c and ldl‐c treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease |
topic | Clinical Trial Result |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933116/ https://www.ncbi.nlm.nih.gov/pubmed/36448416 http://dx.doi.org/10.1002/clc.23948 |
work_keys_str_mv | AT brockmeyermaximilian knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT wiesemilia knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT joergesjamuna knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT sommerjana knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT borgmannsandraolivia knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT chernyaknadja knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT linyingfeng knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT parcoclaudio knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT schulzevolker knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT heinenyvonne knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT kelmmalte knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT icksandrea knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT peringsstefan knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease AT wolffgeorg knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease |